Stimulation of ␤-adrenergic receptors (␤ARs) causes apoptosis in adult rat ventricular myocytes (ARVMs). The role of reactive oxygen species (ROS) in mediating ␤ARstimulated apoptosis is not known. Stimulation of ␤ARs with norepinephrine (10 mol/L) in the presence of prazosin (100 nmol/L) for 24 hours increased the number of apoptotic myocytes as determined by TUNEL staining by 3.6fold. The superoxide dismutase/catalase mimetics Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (MnTMPyP; 10 mol/L) and Euk-134 decreased ␤ARstimulated apoptosis by 89؎6% and 76؎10%, respectively. Infection with an adenovirus expressing catalase decreased ␤AR-stimulated apoptosis by 82؎15%. The mitochondrial permeability transition pore inhibitor bongkrekic acid (50 mol/L) decreased ␤AR-stimulated apoptosis by 76؎8%, and the caspase inhibitor zVAD-fmk (25 mol/L) decreased ␤AR-stimulated apoptosis by 62؎11%. ␤AR-stimulated cytochrome c release was inhibited by MnTMPyP. ␤AR stimulation caused c-Jun NH 2 -terminal kinase (JNK) activation, which was abolished by MnTMPyP. Transfection with an adenovirus expressing dominant-negative JNK inhibited ␤AR-stimulated apoptosis by 81؎12%, and the JNK inhibitor SP600125 inhibited both ␤AR-stimulated apoptosis and cytochrome c release. Thus, ␤AR-stimulated apoptosis in ARVMs involves ROS/JNK-dependent activation of the mitochondrial death pathway.
B eta-adrenergic receptor (␤AR) stimulation in adult rat ventricular myocytes (ARVMs) causes apoptosis, [1] [2] [3] [4] [5] which involves caspase activation. 4 However, little is known about the signals proximal to caspase. Reactive oxygen species (ROS) can cause myocyte apoptosis, 6 -8 and ROS may mediate myocyte apoptosis in response to remodeling stimuli. 9, 10 ROS can induce myocyte apoptosis through c-Jun NH 2 -terminal kinase (JNK)dependent activation of a mitochondrial pathway. 11 We therefore tested the roles of ROS, JNK, and mitochondria in mediating ␤AR-stimulated cardiac myocyte apoptosis.
Materials and Methods

Isolation of ARVMs
ARVMs prepared as previously described 1 were plated 30 to 50 cells/mm 2 on 100-mm plastic culture dishes for Western blotting or 40ϫ22 mm 2 glass coverslips precoated with laminin (1 g/cm 2 , Becton-Dickinson) for TUNEL staining.
Cell Treatments
L-Norepinephrine (NE; 10 mol/L; Sigma) was added for 24 hours (TUNEL), 6 hours (cytochrome c), or 15 minutes (JNK). Prazosin (PZ; 0.1 mol/L; Sigma) was added 30 minutes before NE. All plates were supplemented with ascorbic acid (100 mol/L). Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (MnT-MPyP; 10 mol/L; Calbiochem), Euk-134 12 (Euk; 50 mol/L; Eukarion), bongkrekic acid (BA; 50 mol/L; Calbiochem), zVADfmk (zVAD; 25 mol/L, Calbiochem), and SP600125 (SP; 2 mol/L; Calbiochem) were added 30 minutes before NE.
Western Blotting for Cytochrome c and Phospho-JNK
Mitochondrial cytochrome c release was determined according to Aoki et al. 11 Phospho-JNK and TUNEL staining were determined as previously described. 13 
Adenoviral Infection
ARVMs were infected with adenovirus expressing ␤-galactosidase (10 multiplicity of infection [MOI]), catalase (50 MOI; ATCC), or dominant-negative JNK (10 MOI; the T183A, Y185F JNK1 mutant, 14 courtesy of R. Davis, University of Massachusetts, Worcester, Mass) 48 hours before addition of NE.
Statistical Analysis
All data are meanϮSEM. Differences across multiple conditions were tested by one-way ANOVA for repeated measures. Comparisons between conditions were tested by Student's unpaired t test using the Bonferroni correction for multiple comparisons.
Results
␤AR-Stimulated Apoptosis Is ROS-Dependent and Involves the Mitochondrial Permeability Transition Pore and Caspase Activation
Under control conditions, 4% to 7% of cells were apoptotic as assessed by TUNEL staining. ␤AR stimulation with NE in the presence of PZ (NE/PZ) for 24 hours increased the number of apoptotic myocytes by 3.6Ϯ0.2-fold ( Figure 1A) . The superoxide dismutase (SOD)/catalase mimetics MnTMPyP and Euk decreased the magnitude of ␤AR-stimulated apoptosis by 89Ϯ6% and 76Ϯ10%, respectively ( Figure 1A ). Likewise, infection with an adenovirus expressing catalase decreased ␤AR-stimulated apoptosis by 82Ϯ15% ( Figure 1B ). Bongkrekic acid, an inhibitor of the mitochondrial permeability transition pore, 15 decreased ␤AR-stimulated apoptosis by 76Ϯ8% ( Figure  1A) . The caspase inhibitor zVAD-fmk decreased ␤ARstimulated apoptosis by 62Ϯ11% ( Figure 1A ).
␤AR Stimulation Causes ROS-Dependent Mitochondrial Cytochrome c Release
␤AR stimulation (6 hours) increased cytosolic cytochrome c by 2.1Ϯ0.2-fold ( Figure 1C ). MnTMPyP decreased ␤ARstimulated cytochrome c release to 1.4Ϯ0.3-fold ( Figure 1C ).
␤AR-Stimulated Apoptosis and Cytochrome c Release Are JNK-Dependent
␤AR stimulation (15 minutes) caused a 2.3Ϯ0.4-fold increase in JNK activity. MnTMPyP decreased ␤AR-stimulated JNK activation to 1.0Ϯ0.3-fold ( Figure 2A ). The JNK inhibitor SP600125 16 decreased ␤AR-stimulated apoptosis to 1.3Ϯ0.1fold ( Figure 2B ) and decreased ␤AR-stimulated cytochrome c release to 1.6Ϯ0.4-fold (PϽ0.05; nϭ6). Likewise, infection with an adenovirus expressing dominant-negative JNK, which inhibited JNK activation by Ϸ70% (data not shown), decreased ␤AR-stimulated apoptosis by 81Ϯ12% ( Figure 2C ). 
Discussion
We 1,2 and others [3] [4] [5] have shown that ␤AR stimulation causes apoptosis in ARVMs. In the present study, ␤AR-stimulated apoptosis was inhibited by SOD/catalase mimetics or overexpression of catalase, thereby demonstrating that ROS play a necessary role in ␤AR-stimulated apoptosis and suggesting that the responsible ROS is H 2 O 2 or a derivative.
We found that ␤AR stimulation caused mitochondrial cytochrome c release, which was ROS-dependent, and that the mitochondrial permeability transition pore inhibitor bongkrekic acid 15 decreased ␤AR-stimulated apoptosis, thus implicating the mitochondrial pathway. ROS are known to cause mitochondrial cytochrome c release in cardiac myocytes. 8, 11 ␤AR stimulation in ARVMs causes activation of JNK, p38, and to a lesser extent, extracellular signal-regulated kinase (ERK). 13 In the present study, ␤AR-stimulated JNK activation was inhibited by MnTMPyP, thus indicating that it is ROSdependent. Further, infection with an adenovirus expressing dominant-negative JNK 14 inhibited ␤AR-stimulated apoptosis, and the JNK inhibitor SP60012 16 prevented both ␤ARstimulated apoptosis and cytochrome c release. Thus, ␤AR activation of the mitochondrial death pathway requires the ROS-dependent activation of JNK. JNK can associate with mitochondria and mediate activation of the mitochondrial death pathway in cardiac myocytes in response to H 2 O 2 . 11 In contrast, JNK may exert antiapoptotic effects in neonatal rat cardiac myocytes exposed to nitric oxide, 17 suggesting that the role of JNK is cell-type and/or context-dependent. We previously found that ␤AR-stimulated apoptosis was increased by inhibition of p38 and not affected by inhibition of ERK. 13 It is now recognized that ROS play an important role in signal transduction. 18 We previously found that ␣-adrenergic receptor (␣AR) stimulation causes ROSdependent activation of the ras-raf-MEK-ERK1/2 cascade leading to hypertrophy. 19, 20 In contrast to ␤AR stimulation, ␣AR stimulation does not cause myocyte apoptosis. 19 We have also found that ROS can mediate either hypertrophy or apoptosis in cardiac myocytes in response to mechanical strain, depending on the magnitude of strain. 10 That ␣AR versus ␤AR and different amplitudes of mechanical strain link via ROS to distinct myocyte phenotypes suggests that qualitative and/or quantitative differences in ROS are critical determinants of ROS signaling in cardiac myocytes. The source of ROS that links ␤AR stimulation to apoptosis remains to be determined but may involve mitochondria, xanthine oxidase, NADPH oxidase, nitric oxide synthase, and/or cyclooxygenase.
These findings indicate that ROS play a central role in the regulation of myocyte apoptosis via JNK-dependent activation of the mitochondrial death pathway. ROS are thus a potential new target for the prevention of myocardial failure.
